Name:  ___                 ___ No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
codeine
 
Attending: ___.
 
Chief Complaint:
RUQ pain
 
Major Surgical or Invasive Procedure:
ERCP with sphincterotomy, brushings, placement of metal stent 
 
History of Present Illness:
Patient is a ___ year old man with atrial fibrillation on ASA, 
lung cancer s/p resection, prostate ca, mitral valve disease, 
HTN, who is referred from OSH with abdominal pain in 
periumbilical region. 

Patient reports he has been in his usual state of health until 
this AM when he developed initially epigastric pain, with 
gradual onset ___ pain. The pain then migrated to RUQ region. 
+chills, nausea and NBNB emesis. No sob. No pain currently. 
Presented to ___ and found to be febrile with elevated 
LFTs with US showing biliary dilation with 1.4cm CBD and 
distended gallbladder without stones. CXR clear. Pt was given 
CTX and flagyl and transferred to ___.

In the ED, initial VS were: 98.4 80 130/64 18 95% Nasal Cannula 
ED labs were notable for: 
Cr 1.3
H/H 11.6/34.6
plt 77
AST 123, ALT 83, Alk phos 45, Tbili 1.3

ERCP consulted in ED.  Recommended MRCP.

Transfer VS were: 78 118/52 18 97% Nasal Cannula 

 When seen on the floor, he reports feeling tired. Denies abd 
pain, fever, chills, nausea, vomiting.
  
REVIEW OF SYSTEMS: 
 A ten point ROS was conducted and was negative except as above 
in the HPI.

 
Past Medical History:
Atrial fibrillation
Lung cancer s/p resection
Prostate cancer
HTN
 
Social History:
___
Family History:
no family history of gallstone disease
 
Physical Exam:
Admission PE:
 Gen: NAD, lying in bed
 Eyes: EOMI, sclerae anicteric  
 ENT: MMM, OP clear
 Cardiovasc: RRR, no MRG, full pulses, no edema  
 Resp: normal effort, no accessory muscle use, lungs CTA ___.
 GI: soft, NT, ND, BS+. Negative ___ sign. No rebound 
tenderness or guarding
 MSK: No significant kyphosis. No palpable synovitis.
 Skin: No visible rash. No jaundice.
 Neuro: AAOx3. No facial droop.
 Psych: Full range of affect

Discharge PE:
VS: 98.3 128 / 72 77 18 95 RA 
Gen: NAD, resting comfortably in bed
HEENT: EOMI, PERRLA, MMM, anicteric sclera
CV: RRR nl s1s2 III/VI holosystolic murmur loudest at apex
Resp: CTAB no w/r/r
Abd: Soft, NT, ND +BS, no hepatosplenomegaly
Ext: no c/c/e
Neuro: CN ___ intact, ___ strength throughout
Psych: normal affect
Skin: warm, dry no rashes
GU: no foley

 
Pertinent Results:
___ 12:15AM URINE  ___
___ 12:15AM URINE  ___ SP ___
___ 12:15AM URINE  ___  ___ 
___ 
___
___ 12:15AM URINE  ___ 
EPI-<1
___ 12:15AM URINE  ___
___ 10:50PM   ___ ___
___ 10:44PM   ___
___ 10:30PM   ___ UREA ___ 
___ TOTAL ___ ANION ___
___ 10:30PM   ___ this
___ 10:30PM   ___
___ 10:30PM   ___
___ 10:30PM   ___ 
___

ERCP ___:
Impression: Limited exam of the esophagus was normal 
Limited exam of the stomach was normal 
Limited exam of the duodenum was normal 
The scout film was normal.  
The major papilla was inside a small ampullary diverticulum and 
it appeared normal.  
The CBD was successfully cannulated with the CleverCut 3V 
sphicterotome preloaded with a 0.025in guidewire.  
The guidewire was advanced into the intrahepatic biliary tree.  

Contrast injection revealed a severely dilated CBD to 
approximately 14mm in diameter up to the level of the ampulla.  
The intrahepatic biliary tree was mildly dilated.  
Findings suspicious for ampullary stenosis versus small 
___ tumor. 
A sphincterotomy was successfully performed at the 12 o'clock 
position.  
Mild oozing of blood was noted at the apex of the 
sphincterotomy.  
Brushings were successfully obtained and sample was sent for 
cytology.  
To achieve hemostasis a 10mm X 60mm WallFlex ___ 
metal stent (REF: ___ was placed across the 
ampulla followed by 8mL ___ injection and it was 
successful.  
No bleeding was noted at the end of the procedure. 
The PD was not injected or cannulated. 
Recommendations: Return to ward under ongoing care. 
NPO overnight with aggressive IV hydration with LR at 200 cc/hr 

If no abdominal pain in the morning, advance diet to clear 
liquids and then advance as tolerated 
No Plavix, NSAIDS, Coumadin for 5 days. 
Continue with antibiotics - Ciprofloxacin 500mg BID x 5 days. 
Repeat ERCP/EUS in 3 - 5 weeks for stent pull and 
___. 
Follow up with cytology reports. Please call Dr. ___ 
___ in 7 days for the pathology results 
Follow for response and complications. If any abdominal pain, 
fever, jaundice, gastrointestinal bleeding please call ERCP 
fellow on call ___ (___)
 
Discharge labs:
___ 06:30AM BLOOD ___ 
___ Plt ___
___ 06:30AM BLOOD ___ 
___
___ 06:30AM BLOOD ___ year old man with atrial fibrillation on ASA, lung cancer s/p 
resection, prostate ca, mitral valve disease, HTN, who presents 
with RUQ pain, fever and elevated LFTs with imaging suggestive 
of biliary obstruction.

# RUQ pain
# Dilated bile duct
# Elevated LFT
# Fever
S/p ERCP showing severely dilated CBD without obvious etiology, 
concerning for either papillary stenosis or small ampullary 
tumor.  Brushings taken results currently pending. Had mild 
___ bleeding, s/p injection of epinephrine and 
placement of metal stent with control of bleeding.  Febrile 
initially at OSH but no further fevers here, normal bilirubin, 
no evidence of cholangitis on ERCP.  He was initially given 
Ceftriaxone and Flagyl, narrowed to PO Cipro.  His pain entirely 
resolved after the procedure and he was tolerating a regular 
diet.  Cultures from ___ and ___ NGTD.  
- Continue PO ciprofloxacin for total 5 day course
- Plan for repeat ERCP and likely EUS in ___ weeks
- Follow up with cytology reports. Please call Dr. ___ 
___ in 7 days for the pathology results 

# CKD stage III: Creatinine has been stable at 1.3, per PCP 
records last creatinine 1.4 in ___. 

# Thrombocytopenia: Unclear baseline, initial platelet count at 
___ was 77. No signs of sponatenous bleeding or bruising.  
Last platelet count from PCP office was 138 in ___.  Platelet 
count remained stable.
- Discontinue aspirin until instructed to restart by PCP
- ___ repeat CBC check at next PCP visit, if not improved 
would consider hematology consultation. 

# HTN
- Continue lisinopril and metoprolol

# BPH: Had mild urinary retention post procedure requiring 
straight catheterization x1.  Was able to urinate the next day, 
PVR <300.
- Continue doxazosin, consider outpatient urology ___.  

# FEN: regular 
# PPX: SCD
# Access: PIV
# Disposition: home without services
# Code status: Full
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 5 mg PO DAILY 
2. Metoprolol Tartrate 75 mg PO BID 
3. Doxazosin 4 mg PO BID 
4. AndroGel (testosterone) 1 % (25 mg/2.5gram) transdermal 
2X/WEEK 
5. Furosemide 10 mg PO DAILY 
6. lutein unknown  oral unknown 
7. Vitamin D Dose is Unknown  PO Frequency is Unknown 
8. Acidophilus (Lactobacillus acidophilus)    oral unknown 
9. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day 
Disp #*8 Tablet Refills:*0 
2.  Acidophilus (Lactobacillus acidophilus)  1 cap ORAL DAILY  
3.  lutein 1 cap ORAL DAILY  
4.  Vitamin D 1000 UNIT PO DAILY  
5.  AndroGel (testosterone) 1 % (25 mg/2.5gram) transdermal 
2X/WEEK  
6.  Doxazosin 4 mg PO BID  
7.  Furosemide 10 mg PO DAILY  
8.  Lisinopril 5 mg PO DAILY  
9.  Metoprolol Tartrate 75 mg PO BID  
10. HELD- Aspirin 81 mg PO DAILY  This medication was held. Do 
not restart Aspirin until instructed by your primary care 
physician

 
___:
Home
 
Discharge Diagnosis:
Biliary dilation, possibly due to papillary stenosis or small 
___ tumor
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,

You were admitted with abdominal pain, fevers, nausea and 
vomiting.  You were found to have an enlarged bile duct.  You 
underwent an ERCP procedure showing a very dilated bile duct 
without obvious cause, brushings were taken and are being 
reviewed by our pathologists.  A stent was placed to control 
mild bleeding you had during the procedure.  The ERCP team will 
call you to schedule a repeat endoscopy in ___ weeks to remove 
the stent and ___ the area.

Please ___ with your primary care physician as scheduled.  
Your platelet count was found to be low, please talk with your 
primary care physician about repeating this test at your next 
visit.  We recommend holding your aspirin until you ___ 
with him.  
 
Followup Instructions:
___